The following securities are suspended from trading on the Aquis Growth Market for failure to pay exchange fees pursuant to Rule 3.10 of the Aquis Stock Exchange Rulebook (Access) with effect from today, 10/10/2024:

Mydecine Innovations Group Inc
Ordinary Shares
Symbol: MYIG
ISIN: CA62849F2008


The Regulation Department
Aquis Stock Exchange
Floor 2, 63 Queen Victoria Street, EC4N 4UA
Tel: 0203 597 6361
Email: aqseregulation@aquis.eu
Website: www.aquis.eu/aquis-stock-exchange